Forensic Science International
Volume 198, Issue 1 , Pages 46-52, 20 May 2010

Potential of IRMS technology for tracing gamma-butyrolactone (GBL)

  • François Marclay

      Affiliations

    • Swiss Laboratory for Doping Analyses, University Centre of Legal Medecine, Geneva and Lausanne, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Ch. des Croisettes 22, 1066 Epalinges, Switzerland
    • These authors contributed equally to this work.
  • ,
  • Diego Pazos

      Affiliations

    • Institut de Police Scientifique, Ecole des Sciences Criminelles, Université de Lausanne, Batochime, 1015 Lausanne-Dorigny, Switzerland
    • These authors contributed equally to this work.
  • ,
  • Olivier Delémont

      Affiliations

    • Institut de Police Scientifique, Ecole des Sciences Criminelles, Université de Lausanne, Batochime, 1015 Lausanne-Dorigny, Switzerland
  • ,
  • Pierre Esseiva

      Affiliations

    • Institut de Police Scientifique, Ecole des Sciences Criminelles, Université de Lausanne, Batochime, 1015 Lausanne-Dorigny, Switzerland
    • Corresponding Author InformationCorresponding author at: Institut de Police Scientifique, 1015 Lausanne-Dorigny, Switzerland. Tel.: +41 216924652; fax: +41 216924605.
  • ,
  • Christophe Saudan

      Affiliations

    • Swiss Laboratory for Doping Analyses, University Centre of Legal Medecine, Geneva and Lausanne, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Ch. des Croisettes 22, 1066 Epalinges, Switzerland

Received 19 August 2009; received in revised form 3 December 2009; accepted 8 December 2009. published online 07 January 2010.

Abstract 

Popularity of γ-hydroxybutyric acid (GHB) is fairly stable among drug users, while the consumption of its chemical precursor, γ-butyrolactone (GBL), is a growing phenomenon. Although conventional analytical methods allow to detect this substance in various matrices, linking a trace and a source is still a difficult challenge. However, as several synthesis pathways and chemical precursors exist for the production of GBL, its carbon isotopic signature may vary extensively. For that purpose, a method has been developed to determine the carbon isotopes content of GBL by means of gas chromatography/combustion/isotope ratio mass spectrometry (GC/C/IRMS).

The δ13C-values of 19 bulk samples purchased worldwide were in the range from −23.1 to −45.8‰ (SD<0.3‰). Furthermore, testing on the purification of GBL by distillation has not been found to be consistent with such a large range of δ13C-values, which are likely to result from the isotopic composition of the organic precursors used to produce GBL together with the kinetic isotope effect associated with the synthesis routes. Finally, inter- and intra-variability measurements of the δ13C-values demonstrated the high potential of IRMS for discriminating between seizures of GBL and for source determination.

Keywords: Drug of abuse, Isotope ratio mass spectrometry, Gamma hydroxy butyric acid, Gamma butyrolactone

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0379-0738(09)00493-9

doi:10.1016/j.forsciint.2009.12.014

Forensic Science International
Volume 198, Issue 1 , Pages 46-52, 20 May 2010